Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has The Kidney Fibrosis Treatment Market Growth Evolved From 2024 To 2025, And What’s Ahead?

The market size for treatment of kidney fibrosis has seen substantial growth in the past few years. The prediction is that it will increase from $5.62 billion in 2024 to $6.06 billion in 2025, marking a compound annual growth rate (CAGR) of 7.8%. The historical growth is largely due to increased investment in research and development for therapies focused on fibrosis, enhanced government support for initiatives managing kidney diseases, heightened patient consciousness about opportunities for kidney transplantation and fibrosis treatment, an expansion of health care facilities, and the growing number of elderly individuals.

Growth predictions anticipate significant enlargement for the kidney fibrosis treatment market in the coming few years. The market is projected to escalate to $8.21 billion by 2029, with a compound annual growth rate of 7.9%. Several contributing factors driving the growth during the forecast period include an escalating number of chronic kidney disease cases, enhanced demand for state-of-the-art renal fibrosis therapies, and a growing recognition of early kidney fibrosis detection. Other influences include the heightening attention to personalized medicine in treating kidney disease, and the increasing occurrence of diabetes and hypertension. Major trends for the forecast period incorporate advancements in technology for early detection and diagnostic tools, progression in gene therapy initiatives, the incorporation of technology in telemedicine and remote oversight, advancements in stem cell therapies, along with improvements in drug delivery systems.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24271&type=smp

What External and Internal Drivers Are Contributing to the Growth of theKidney Fibrosis Treatment Market?

The escalation in the occurrence of chronic kidney diseases is projected to spur the expansion of the kidney fibrosis treatment market in the future. Chronic kidney disease (CKD) characterizes a steady deterioration of kidney function over a span of time, often as a result of conditions such as diabetes or hypertension. This eventual deterioration leads to the build-up of waste products within the body. The growth in the prevalence of CKD is mainly attributable to the increasing instances of diabetes, which harms the kidney blood vessels and hinders their ability to filter. Kidney fibrosis treatment aids CKD patients by focusing on the scarring of the kidney tissue, lessening inflammation, and decelerating kidney damage, which all aid in the conservation of kidney function. To illustrate, in May 2024, the Centers for Disease Control and Prevention (CDC), a public health agency in the US, estimated that about 14% of adults in the U.S., or around 35.5 million people, are thought to be affected with chronic kidney diseases. Hence, the rising occurrence of chronic kidney diseases is stimulating the advancement of the kidney fibrosis treatment market.

What Segment Types Define the Kidney Fibrosis Treatment Market Structure?

The kidney fibrosis treatment market covered in this report is segmented –

1) By Treatment Type: Angiotensin-Converting Enzyme (Ace) Inhibitors, Angiotensin Ii Receptor Blockers (Arbs), Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors, Other Treatment Types

2) By Diagnosis: Blood Tests, Urine Tests, Imaging Tests, Kidney Biopsy

3) By Application: Chronic Kidney Diseases, Kidney Cancer Treatment, Other Applications

4) By End-User: Clinics, Research Center, Hospitals

Subsegments:

1) By Angiotensin-Converting Enzyme (Ace) Inhibitors: Enalapril, Captopri, Lisinopril, Ramipril

2) By Angiotensin Ii Receptor Blockers (Arbs): Losartan, Telmisartan, Valsartan, Irbesartan

3) By Pirfenidone: Branded Pirfenidone, Generic Pirfenidone

4) By Renin Inhibitors: Aliskiren, Experimental Renin Inhibitors

5) By Vasopeptidase Inhibitors: Omapatrilat, Sampatrilat

6) By Other Treatment Types: Anti-Inflammatory Agents, Stem Cell Therapy, Antifibrotic Agents Under Clinical Trials, Gene Therapy

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=24271&type=smp

Which Geographic Areas Hold the Strongest Growth Potential in the Kidney Fibrosis Treatment Market?

North America was the largest region in the kidney fibrosis treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the kidney fibrosis treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

View the full report here:

https://www.thebusinessresearchcompany.com/report/kidney-fibrosis-treatment-global-market-report

What Is the Definition of the Kidney Fibrosis Treatment Market?

Kidney fibrosis treatment refers to therapeutic strategies aimed at slowing, halting, or reversing the progression of fibrosis in the kidneys. Kidney fibrosis is the excessive accumulation of extracellular matrix proteins such as collagen, resulting to scarring and functional decline of kidney tissue, commonly associated with chronic kidney disease (CKD).

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=24271

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model